Atherosclerosis

Instructions to authors
pp. iii-iii(1)

Instructions to authors
pp. I-I(1)

The use of antioxidant supplements in coronary heart disease
pp. 211-219(9)
Authors: Kritharides L.; Stocker R.

Effect of gemfibrozil on apolipoprotein B secretion and diacylglycerol acyltransferase activity in human hepatoblastoma (HepG2) cells
pp. 221-228(8)
Authors: Zhu D.; Ganji S.H.; Kamanna V.S.; Kashyap M.L.

Effect of dietary copper supplementation on cell composition and apoptosis in atherosclerotic lesions of cholesterol-fed rabbits
pp. 229-236(8)
Authors: Lamb D.J.; Avades T.Y.; Allen M.D.; Anwar K.; Kass G.E.N.; Ferns G.A.A.

d-erythro-N,N-dimethylsphingosine inhibits bFGF-induced proliferation of cerebral, aortic and coronary smooth muscle cells
pp. 237-243(7)
Authors: Xu C.-B.; Zhang Y.; Stenman E.; Edvinsson L.

ABCA1_Alabama: a novel variant associated with HDL deficiency and premature coronary artery disease
pp. 245-250(6)
Authors: Hong S.H.; Rhyne J.; Zeller K.; Miller M.

Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice
pp. 251-259(9)
Authors: Rosenfeld M.E.; Kauser K.; Martin-McNulty B.; Polinsky P.; Schwartz S.M.; Rubanyi G.M.

Potential role of platelet FcRIIA in collagen-mediated platelet activation associated with atherothrombosis
pp. 261-267(7)
Authors: Calverley D.C.; Brass E.; Hacker M.R.; Tsao-Wei D.D.; Espina B.M.; Pullarkat V.A.; Hodis H.N.; Groshen S.

Influence of a glutamate carboxypeptidase II (GCPII) polymorphism (1561C->T) on plasma homocysteine, folate and vitamin B₁₂ levels and its relationship to cardiovascular disease risk
pp. 269-273(5)
Authors: Lievers K.J.A.; Kluijtmans L.A.J.; Boers G.H.J.; Verhoef P.; den Heijer M.; Trijbels F.J.M.; Blom H.J.

Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction
pp. 275-281(7)
Authors: Yli-Jama P.; Seljeflot I.; Meyer H.E.; Hjerkinn E.M.; Arnesen H.; Pedersen J.I.

Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males
pp. 283-288(6)
Authors: Barud W.; Palusinski R.; Beltowski J.; Wojcicka G.

The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs
pp. 289-295(7)
Authors: Gnasso A.; Motti C.; Irace C.; Di Gennaro I.; Pujia A.; Leto E.; Ciamei M.; Crivaro A.; Bernardini S.; Federici G.; Cortese C.

Soluble intercellular adhesion molecule-1 is associated with carotid and femoral atherosclerosis but not with intima-media thickness in a population-based sample
pp. 297-304(8)
Authors: Bongard V.; Elias A.; Bal dit Sollier C.; Ruidavets J.-B.; Boccalon H.; Drouet L.; Ferrieres J.

Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk
pp. 305-311(7)
Authors: Gonbert S.; Malinsky S.; Sposito A.C.; Laouenan H.; Doucet C.; Chapman M.J.; Thillet J.

Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population
pp. 313-319(7)
Authors: Maeda N.; Sawayama Y.; Tatsukawa M.; Shimizu C.; Kashiwagi S.; Hayashi J.

Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese
pp. 321-328(8)
Authors: Moriyama Y.; Okamura T.; Kajinami K.; Iso H.; Inazu A.; Kawashiri M.; Mizuno M.; Takeda Y.; Sakamoto Y.; Kimura H.; Suzuki H.; Mabuchi H.

Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study
pp. 329-335(7)
Authors: Pollanen P.J.; Lehtimaki T.; Ilveskoski E.; Mikkelsson J.; Kajander O.A.; Laippala P.; Perola M.; Goebeler S.; Penttila A.; Mattila K.M.; Syrjakoski K.; Koivula T.; Nikkari S.T.; Karhunen P.J.

Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus
pp. 337-346(10)
Authors: van der Kallen C.J.H.; Voors-Pette C.; Bouwman F.G.; Keizer H.A.; Lu J.Y.; van de Hulst R.R.W.J.; Bianchi R.; Janssen M.-J.; Keulen E.T.P.; Boeckx W.D.; Rotter J.I.; de Bruin T.W.A.

Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia - The examination of probands and relatives in Statin studies with familial hypercholesterolemia (ExPRESS FH)
pp. 347-354(8)
Authors: de Sauvage Nolting P.R.W.; Buirma R.J.A.; Hutten B.A.; Kastelein J.J.P.; The Dutch ExPRESS investigators Group

C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina
pp. 355-359(5)
Authors: Zairis M.N.; Papadaki O.A.; Manousakis S.J.; Thoma M.A.; Beldekos D.J.; Olympios C.D.; Festeridou C.A.; Argyrakis S.K.; Foussas S.G.

Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients
pp. 361-369(9)
Authors: Asztalos B.F.; Horvath K.V.; McNamara J.R.; Roheim P.S.; Rubinstein J.J.; Schaefer E.J.

Predictive value of preprocedural fibrinogen concerning coronary stenting
pp. 371-378(8)
Authors: Otsuka M.; Hayashi Y.; Ueda H.; Imazu M.; Kohno N.

Letter in response to recent paper by Fournier et al.
pp. 379-380(2)
Authors: Dullaart R.P.F.; van Tol A.

Treatment of children with familial hypercholesterolemia with colestilan, a newly developed bile acid-binding resin
pp. 381-382(2)
Authors: Asami T.; Uchiyama M.

Homocysteine and cardiovascular disease in diabetes mellitus
pp. 383-384(2)
Authors: Jeremy J.Y.; Shukla N.; Angelini G.D.

Characterization of thrombomodulin gene mutations of the 5'-regulatory region
pp. 385-387(3)
Authors: Nakazawa F.; Koyama T.; Shibamiya A.; Hirosawa S.

Erratum to: ''Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes'' - [Atherosclerosis 160 (2002) 21-30]
pp. 389-389(1)
Authors: Theriault A.; Chao J.-T.; Gapor A.

Author index
pp. 391-394(4)

Subject index
pp. 395-396(2)